1. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects. New England Journal of Medicine 2000;343:1608-1614.
  2. Cooper W, Hernández-Díaz S, Arbogast PG, Dudley J, Dyer S, Gideon P, Hall K, Ray WA. Angiotensin-converting enzyme inhibitors and the risk of major congenital malformations. New England Journal of Medicine  2006; 354:2443-51.
  3. Chambers C, Hernández-Díaz S, Van Marter L, Werler MM, Jones KL, Louik C, Mitchell AA. Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn. New England Journal of Medicine 2006;354:579-87.
  4. Hernández-Díaz S, Toh S, Cnattingius S. Risk of preeclampsia in first and subsequent pregnancies: prospective cohort study British Medical Journal 2009;338:b2255.
  5. Palmsten K, Setoguchi S, Margulis AV, Patrick AR, Hernández-Díaz S.  Elevated Risk of Preeclampsia in Pregnant Women with Depression: Depression vs. Antidepressants. Am J Epidemiol 2012;175:988-97.
  6. Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes BH for the North American AED (Antiepileptic Drug) Pregnancy Registry. Comparative Safety of Antiepileptic Drugs during Pregnancy. Neurology 2012;78:1692-1699.
  7. Huybrechts K, Palmsten K, Avorn J, Cohen LJ, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S. Antidepressant Use in Pregnancy and the Risk of Cardiac Defects. New England Journal of Medicine.2014;370:2397-407.
  8. Bateman BT, Huybrechts K, Fischer MA, Seely EW, Oberg AS, Franklin JM, Mogun H, Hernández-Díaz S. Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. 2014. [Epub ahead of print] PMID: 25265405
  9. MacDonald SC, Bateman BT, McElrath TF, Hernández-Díaz S. Maternal Mortality and Morbidity in Pregnant Women with Epilepsy in the United States. JAMA Neurol. 2015 [Epub ahead of print] PMID: 26147878
  10. Huybrechts K, Bateman B, Palmsten K, Desai R, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernández-Díaz S. Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn Among US Medicaid Beneficiaries. JAMA. 2015;313(21):2142-51


  1. Hernández-Díaz S, García-Rodríguez LA. Non-Steroidal Anti-inflammatory Drugs and the Risk of Lung Cancer. International Journal of Cancer. 2007;120:1565-72.
  2. Hernández-Díaz S, C Varas-Lorenzo, García Rodríguez LA. Non-steroidal Anti-inflammatory Drugs and the Risk of Acute Myocardial Infarction. Systematic Review of Observational Studies. Basic Clinical Pharmacology and Toxicology. 2006; 98:266-74.
  3. García-Rodríguez LA, Hernández-Díaz S. Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Non-Steroidal Anti-Inflammatory Drugs. American Journal of Epidemiology. 2004;159:23-31.
  4. García-Rodríguez LA, Hernández-Díaz S. Non-Steroidal Anti-Inflammatory Drugs as a Triggering of Clinical Heart Failure. Epidemiology. 2003;14:240-6.
  5. Hernández-Díaz S, García-Rodríguez LA. Overview of Epidemiological Studies Published in the Nineties on the Association Between Non-Steroidal Anti-inflammatory Drugs and Upper Gastrointestinal Bleed/Perforation. Archives of Internal Medicine 2000;160:2093-2099.


  1. Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA. Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology. American Journal of Epidemiology 2002; 155:176-184.
  2. Hernández-Díaz S, Hernán MA, Meyer K, Werler MM, Mitchell AA. Case-Crossover and Case-Time-Control Designs in Birth Defects Epidemiology. American Journal of Epidemiology 2003;158:385-391.
  3. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004; 15: 615-625.
  4. Hernández-Díaz S, Schisterman EF, Hernán MA. The birth weight “paradox” uncovered? American Journal of Epidemiology 2006;164:1115-20.
  5. Toh S, Mitchell AA, Werler MM, Hernández-Díaz S. Sensitivity and Specificity of Computerized Algorithms to Classify Gestational Periods in the Absence of Information on Date of Conception. American Journal Epidemiology 2008: 167:633-40.
  6. VanderWeele TJ, Hernández-Díaz S, Hernán MA. Case-only gene-environment interaction studies: when does association imply mechanistic interaction?”. Genetic Epidemiology 2010; 34:327-34.
  7. Toh S, Hernández-Díaz S, Logan R, Robins JM, Hernán MA. Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology 2010; 21:528-39.
  8. Hernán MA, Hernández-Díaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials.2012;9:48-55.
  9. Palmsten K, Huybrechts KF, Mogun H, Kowal MK, Williams PL, Michels KB, Setoguchi S, Hernández-Díaz S. Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One 2013;8(6):e67405
  10. Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts K. Methodological Considerations in Assessing the Effectiveness of Antidepressant Medication Continuation during Pregnancy using Administrative Data. Pharmacoepidemiol Drug Saf. 2015. 24(9):934-42. PMID: 26045370.